Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity; A 5-year prospective follow-up study variation of insulin sensitivity in HCV patients

Internal Medicine Journal

Volumn 40, Issue 7, 2010, Pages 503-511

  Park, S K ^a   Cho, Y K ^a   Park, J H ^a   Kim, H J ^a   Park, D I ^a   Sohn, C I ^a   Jeon, W K ^a   Kim, B I ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

HCV infection; HOMA IR; insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEPATITIS C ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FATTY LIVER; FEMALE; FOLLOW UP; GENOTYPE; GLUCOSE TOLERANCE; HEPATITIS C; HOMEOSTASIS; HUMAN; IMMUNORADIOMETRIC ASSAY; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERNATIONAL NORMALIZED RATIO; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77954652502     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02042.x     Document Type: Article

References (43)

1. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996 19 : 998 1000.
2. Ozyilkan E, Erbas T, Simsek H, Telatar F, Kayhan B, Telatar H. Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med 1994 235 : 283 285.
3. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in United states. Ann Intern Med 2000 133 : 592 599.
4. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepato 2001 35 : 279 283.
5. Mason AL, Nair S. Is type II diabetes another extrahepatic manifestation of HCV infection? Am J Gastroenterol 2003 98 : 243 246.
6. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J et al. Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 30 : 1059 1063.
7. Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008 134 : 416 423.
8. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005 90 : 3498 3504.
9. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985 727 113.
10. Lee CJ, Shin WW, Ahn HS, Lee SW, Roh MH, Han SY et al. Genotype in patients with chronic liver disease associated with hepatitis C virus infection. Korean J Gastroenterol 2000 35 : 73 81.
11. Lee GC, Kim HG, Park NH, Yoon HA, Baek YH, Kim MJ et al. Distribution of hepatitis C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection. Korean J Hepatol 2008 14 : 36 45.
12. Dinneen SF, Madonado D III., Leibson CL, Klee GG, Li H, Melton LJ et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 1998 21 : 1408 1413.
13. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or inpaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 1999 22 : 399 402.
14. Allison MED, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994 21 : 1135 1139.
15. Mason AL, Lau JYN, Hong N, Qian K, Alexander GJ, Xu L et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 29 : 328 323.
16. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996 32 : 526 530.
17. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance and insulin secretion in chronic hepatitis C patients. Diabetes Care 2006 29 : 1096 1101.
18. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003 125 : 1695 1704.
19. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of cytokine signaling 3. Am J Pathol 2004 165 : 1499 1508.
20. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000 31 : 694 703.
21. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002 17 : 677 681.
22. Kato M, Asano H, Miwa Y, Tajika M, Yamato M, Tomita E et al. Insulin sensivitivy and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis. Hepatol Res 2000 17 : 93 101.
23. Macedo G, Ribeiro T. Cirrhosis and diabetes: C, the difference. Am J Gastroenterol 1999 94 : 3088 3089.
24. Gentile S, Loguercio C, Marmo R, Carbone L, Del Vecchio Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993 22 : 37 44.
25. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994 20 : 119 125.
26. Petrides AS, Schulze-Berge D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993 18 : 284 291.
27. de Veget F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001 285 : 2109 2113.
28. Narita R, Abe S, Tabaru A, Otsuki M. Impact of steatosis on insulin secretion in chronic hepatitis C patients. Am J Gastroenterol 2007 102 : 2173 2180.
29. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 2003 39 : 1042 1048.
30. Taura N, Ichikawa T, Hamasaki K, Nakao K, Nishimura D, Goto T et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol 2006 101 : 1 8.
31. Goodman ZD, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002 122 : 1649 1657.
32. Czaja AJ, Carpentero HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998 29 : 198 206.
33. Patel K, Zekry A, McHutchison JG. Steatosis and chronic hepatitis C virus infection: mechanisms and significance. Clin Liver Dis 2005 9 : 399 410. (Pubitemid 40968203)
34. Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003 3 : 293 298.
35. Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatol 2006 44 : 1648 1655.
36. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984 3 : 9 14.
37. Gaif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000 35 : 319 324.
38. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 1986 146 : 1011 1015.
39. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 : 3160 3167.
40. Unwin N, Shaw J, Zimmer P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 2002 19 : 708 723.
41. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Disease. The prevention or delay of type 2 diabetes. Diabetes Care 2002 25 : 742 749. Correction published in Diabetes Care 2002 25 : 947.
42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
43. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002 25 : 1135 1141.